American Cancer Society. Cancers linked to infectious disease. Cancer Facts & Figures 2005. Atlanta, GA: American Cancer Society; 2005.
Anttila T, Saikku P, Koskela P, et al. Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA. 2001;285:47–51.
Armstrong GL, Wasley A, Simard EP, et al. The prevalence of Hepatitis C Virus infection in the United States, 1999 through 2002. Ann Int Med. 2006;144;705–714.
Ault KA. Epidemiology and natural history of human papillomavirus infections in the female genital tract. Infect Dis Obstet Gynecol. 2006;Suppl:40470.
Bialasiewicz S, Lambert SB, Whiley DM, et al. Merkel cell polyomavirus DNA in respiratory specimens from children and adults. Emerg Infect Dis [serial on the Internet]. 2009 Mar. Accessed at www.cdc.gov/EID/content/15/3/492.htm on February 6, 2013.
Bonnet F, Lewden C, May T, et al. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Cancer. 2004;101:317–324.
Borges JD, Souza VA, Giambartolomei C, et al. Transmission of human herpesvirus type 8 infection within families in American indigenous populations from the Brazilian Amazon. J Infect Dis. 2012;205:1869-1876.
Brown LM. Helicobacter pylori: epidemiology and routes of transmission. Epidemiol Rev. 2000;22:283–297.
Buchschacher GL Jr, Wong-Staal F. RNA Viruses. In DeVita VT, Lawrence TS, Rosenberg SA (eds). Cancer: Principles & Practice of Oncology, 9th ed. Philadelphia: Lippincott Williams & Wilkins; 2011: 186–192.
Caskey MF, Morgan DJ, Porto AF, et al. Clinical manifestations associated with HTLV type I infection: a cross-sectional study. AIDS Res Hum Retroviruses. 2007;23:365−371.
Centers for Disease Control and Prevention. Viral Hepatitis Statistics and Surveillance. Accessed at http://cdc.gov/hepatitis/Statistics/index.htm on February 6, 2013.
Chen T, Hedman L, Mattila PS, Serological evidence of Merkel cell polyomavirus primary infections in childhood. J Clin Virol. 2011;50:125−129.
Chen T, Hudnall SD. Anatomical mapping of human herpesvirus reservoirs of infection. Modern Pathology. 2006;19:726–737.
Colvin HM, Mitchell AE, Editors; Committee on the Prevention and Control. Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C 2010. Accessed at www.cdc.gov/hepatitis/PDFs/IOM-HepatitisAndLiverCancerReport.pdf on February 14, 2013.
Cote TR, Biggar RJ, Rosenberg PS, et al. Non-Hodgkin’s lymphoma among people with AIDS: incidence, presentation and public health burden. Int J Cancer. 1997;73:645–650.
Engels EA, Atkinson JO, Graubard BI, et al. Risk factors for human herpesvirus 8 infection among adults in the United States and evidence for sexual transmission. J Infect Dis. 2007;196:199−207.
Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science. 2008;319:1096–1100.
Heymann DL (Ed.) Control of Communicable Diseases Manual, 19th ed. Washington DC: American Public Health Association; 2008:393–402.
Holzinger F, Z’graggen K, Buchler MW. Mechanisms of biliary carcinogenesis: a pathogenetic multi-stage cascade towards cholangiocarcinoma. Ann Oncol. 1999;10:122–126.
Howley PM, Ganem D, Kieff E. DNA Viruses. In DeVita VT, Lawrence TS, Rosenberg SA (eds). Cancer: Principles & Practice of Oncology, 9th ed. Philadelphia: Lippincott Williams & Wilkins; 2011: 173−185.
Lanoy E, Dores GM, Madeleine MM, et al. Epidemiology of nonkeratinocytic skin cancers among persons with AIDS in the United States. AIDS. 2009;23:385–393.
Lambert PF, Sugden B. Viruses and Human Cancer. In: Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB, McKenna WG, eds. Abeloff’s Clinical Oncology. 4th ed. Philadelphia, Pa: Elsevier Churchill Livingstone; 2008:153–169.
Lowy DR, Schiller JT. Preventive Cancer Vaccines. In DeVita VT, Lawrence TS, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 8th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2008:548−555.
Manfredi JJ, Dong J, Liu WJ, et al. Evidence against a role for SV40 in human mesothelioma. Cancer Research. 2005;65:2602–2609.
Montaño DE, Kasprzyk D, Carlin L, Freeman C. Executive Summary Results from: HPV Provider Survey: Knowledge, Attitudes, and Practices About Genital HPV Infection and Related Conditions, 2005. Accessed at www.cdc.gov/std/hpv/HPVProviderSurveyExecSum.pdf on February 13, 2013.
Mork J, Lie AK, Glattre E, et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med. 2001;344:1125–1131.
Nagachinta T, Duerr A, Suriyanon V, et al. Risk factors for HIV-1 transmission from HIV-seropositive male blood donors to their regular female partners in northern Thailand. AIDS. 1997;11:1765–1772.
National Cancer Institute. Helicobacter pylori and cancer Fact Sheet. Accessed at www.cancer.gov/cancertopics/factsheet/Risk/h-pylori-cancer on February 13, 2013.
National Cancer Institute. Simian Virus 40 and Human Cancer: Fact Sheet. Accessed at www.cancer.gov/cancertopics/factsheet/simian-virs-40 on August 29, 2011. Content no longer available.
National Cancer Institute. Studies find no evidence that SV40 is related to human cancer. Accessed at http://www.cancer.gov/newscenter/pressreleases/2004/sv40 on February 13, 2013.
Poiesz BJ, Papsidero LD, Ehrlich G, et al. Prevalence of HTLV-I-associated T-cell lymphoma. Am J Hematol. 2001;66:32–38.
Qu L, Jenkins F, Triulzi DJ. Human herpesvirus 8 genomes and seroprevalence in United States blood donors. Transfusion. 2010;50:1050–1056.
Sahasrabuddhe VV, Shiels MS, McGlynn KA, Engels EA. The risk of hepatocellular carcinoma among individuals with acquired immunodeficiency syndrome in the United States. Cancer. 2012;118:6226–6233.
Samoff E, Koumans EH, Markowitz LE, et al. Association of Chlamydia trachomatis with persistence of high-risk types of human papillomavirus in a cohort of female adolescents. Am J Epidemiol. 2005;162:668–675.
Silins I, Ryd W, Strand A, et al. Chlamydia trachomatis infection and persistence of human papillomavirus. Int J Cancer. 2005;116:110–115.
Smith BD, Morgan RL, Beckett GA, et al; Centers for Disease Control and Prevention. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Recomm Rep. 2012 Aug 17;61(RR-4):1–32.
Strickler HD, Goedert JJ, Devesa SS, et al. Trends in U.S. pleural mesothelioma incidence rates following simian virus 40 contamination of early poliovirus vaccines. J Natl Cancer Inst. 2003;95:38–45.
Talley NJ, Fock KM, Moayyedi P. Gastric Cancer Consensus Conference Recommends Helicobacter pylori Screening and Treatment in Asymptomatic Persons From High-Risk Populations to Prevent Gastric Cancer. Am J Gastroenterol. 2008;103:510–514.
Trinchieri G. Inflammation. In DeVita VT, Lawrence TS, Rosenberg SA (eds). Cancer: Principles & Practice of Oncology, 9th ed. Philadelphia: Lippincott Williams & Wilkins; 2011: 193–202.
Verteramo R, Pierangeli A, Mancini E, et al. Human papillomaviruses and genital co-infections in gynaecological outpatients. BMC Infect Dis. 2009;9:16.
Vilchez RA, Kozinetz CA, Butel JS. Conventional epidemiology and the link between SV40 and human cancers. Lancet Oncol. 2003;4:188–191.
Last Medical Review: 02/20/2013
Last Revised: 03/07/2013